{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:15:46Z","timestamp":1761581746805,"version":"build-2065373602"},"reference-count":93,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K1809301, Q1625561"],"award-info":[{"award-number":["K1809301, Q1625561"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Vascular inflammation plays a central role in atherosclerosis, from initiation and progression to acute thrombotic complications. Modified low-density lipoproteins (LDLs) and apoB-containing particles stimulate plaque inflammation by interacting with macrophages. Loss of function of high-density lipoprotein (HDL) for preventing LDL particles from oxidative modification in dyslipidemic states may amplify modified LDL actions, accelerating plaque inflammation. Diets are one of the most important factors that can affect these processes of lipoprotein oxidation and vascular inflammation. Recently, 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has emerged as a reliable noninvasive imaging modality for identifying and quantifying vascular inflammation within atherosclerotic lesions based on the high glycolytic activity of macrophages infiltrating active atherosclerotic plaques. Vascular inflammation evaluated by FDG PET has been positively related to metabolic syndrome components and traditional risk factors of cardiovascular disease, including high-sensitivity C-reactive protein, body mass index, and insulin resistance. A positive association of vascular inflammation with endothelial dysfunction, resistin levels, pericardial adipose tissue, and visceral fat area has also been reported. In contrast, HDL cholesterol and adiponectin have been inversely related to vascular inflammation detected by FDG PET. Because of its reproducibility, serial FDG PET shows potential for tracking the effects of dietary interventions and other systemic and local antiatherosclerotic therapies for plaque inflammation.<\/jats:p>","DOI":"10.3390\/nu10101382","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T10:31:28Z","timestamp":1538130688000},"page":"1382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diet-Modulated Lipoprotein Metabolism and Vascular Inflammation Evaluated by 18F-fluorodeoxyglucose Positron Emission Tomography"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4058-1738","authenticated-orcid":false,"given":"You-Bin","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Mook","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"ref_1","first-page":"e29","article-title":"Heart disease and stroke statistics--2015 update: A report from the american heart association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccl.2017.10.001","article-title":"Impact of lipoproteins on atherobiology: Emerging insights","volume":"36","author":"Feng","year":"2018","journal-title":"Cardiol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.ATV.16.11.1347","article-title":"Effect of dietary fat saturation on ldl oxidation and monocyte adhesion to human endothelial cells in vitro","volume":"16","author":"Mata","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurheartj\/ehi605","article-title":"Diet and inflammation: A link to metabolic and cardiovascular diseases","volume":"27","author":"Esposito","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1038\/s41598-017-06455-x","article-title":"Inflammatory potential of diet and risk of cardiovascular disease or mortality: A meta-analysis","volume":"7","author":"Zhong","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/01.ATV.20.11.2408","article-title":"Apolipoprotein concentrations during treatment and recurrent coronary artery disease events","volume":"20","author":"Westerveld","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/CIRCRESAHA.113.301562","article-title":"A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic\/therapeutic discoveries using gene and microrna expression profiling","volume":"113","author":"Chen","year":"2013","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","author":"Williams","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.CIR.103.7.993","article-title":"Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits","volume":"103","author":"Fukumoto","year":"2001","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1373\/clinchem.2003.026070","article-title":"Atorvastatin lowers plasma matrix metalloproteinase-9 in patients with acute coronary syndrome","volume":"50","author":"Xu","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.18.11.1671","article-title":"Hmg-coa reductase inhibitors reduce mmp-9 secretion by macrophages","volume":"18","author":"Bellosta","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0735-1097(98)00487-2","article-title":"HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis","volume":"32","author":"Bustos","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0192-0561(96)00068-9","article-title":"Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line","volume":"18","author":"Niwa","year":"1996","journal-title":"Int. J. Immunopharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein. The cholesterol and recurrent events (care) investigators","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on c-reactive protein levels: The pravastatin inflammation\/CRP evaluation (PRINCE): A randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.103.15.1933","article-title":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels","volume":"103","author":"Jialal","year":"2001","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N. Eng. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Eng. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) investigators","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: A triumph of simplicity","volume":"27","author":"Boren","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_23","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N. Eng. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/ATVBAHA.108.179697","article-title":"Oxidized low-density lipoprotein and atherosclerosis","volume":"30","author":"Steinberg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.pharmthera.2007.10.004","article-title":"Hypertension and dyslipidaemia in obesity and insulin resistance: Pathophysiology, impact on atherosclerotic disease and pharmacotherapy","volume":"117","author":"Chapman","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.108.118919","article-title":"Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor","volume":"53","author":"Spillmann","year":"2009","journal-title":"Hypertension"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","article-title":"Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque","volume":"103","author":"Shaw","year":"2008","journal-title":"Circ. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1538-7836.2008.03175.x","article-title":"ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans","volume":"7","author":"Birjmohun","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/bbrc.1997.7236","article-title":"Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins","volume":"238","author":"Calabresi","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-2275(20)33375-7","article-title":"Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells","volume":"40","author":"Baker","year":"1999","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/ATVBAHA.110.211342","article-title":"High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo","volume":"30","author":"Bursill","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","article-title":"High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus","volume":"119","author":"Drew","year":"2009","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.freeradbiomed.2006.07.006","article-title":"Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells","volume":"41","author":"Dousset","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0049-3848(90)90095-T","article-title":"Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity","volume":"58","author":"Speidel","year":"1990","journal-title":"Thromb. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/S0021-9258(18)53740-6","article-title":"Interaction between apolipoproteins A-Iand A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9","volume":"268","author":"Hamilton","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/01.ATV.17.10.2158","article-title":"HDL and ApoA prevent cell death of endothelial cells induced by oxidized HDL","volume":"17","author":"Suc","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1096\/fj.02-0240fje","article-title":"HDL counterbalance the proinflammatory effect of oxidized HDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells","volume":"17","author":"Robbesyn","year":"2003","journal-title":"FASEB J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/CIRCRESAHA.110.217281","article-title":"ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis","volume":"106","author":"Pagler","year":"2010","journal-title":"Circ. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","article-title":"Inflammatory\/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment","volume":"108","author":"Ansell","year":"2003","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0735-1097(02)01741-2","article-title":"Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals","volume":"39","author":"Nappo","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11883-004-0089-3","article-title":"Postprandial lipid oxidation and cardiovascular disease risk","volume":"6","author":"Bowen","year":"2004","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ajcn\/78.6.1135","article-title":"Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus","volume":"78","author":"Esposito","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1001\/jama.288.20.2569","article-title":"Optimal diets for prevention of coronary heart disease","volume":"288","author":"Hu","year":"2002","journal-title":"JAMA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jn\/135.3.562","article-title":"Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction","volume":"135","author":"Schulze","year":"2005","journal-title":"J. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/01.hjr.0000152243.51327.2a","article-title":"Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia","volume":"11","author":"Pirro","year":"2004","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/jn\/134.7.1806","article-title":"Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women","volume":"134","author":"Schulze","year":"2004","journal-title":"J. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.292.12.1440","article-title":"Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial","volume":"292","author":"Esposito","year":"2004","journal-title":"JAMA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0008-6363(02)00515-1","article-title":"Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs","volume":"56","author":"Verhamme","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"ref_52","first-page":"2051","article-title":"Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy","volume":"46","author":"Hartung","year":"2005","journal-title":"J. Nucl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Casas, R., Sacanella, E., Urpi-Sarda, M., Chiva-Blanch, G., Ros, E., Martinez-Gonzalez, M.A., Covas, M.I., Salas-Salvado, J., Fiol, M., and Aros, F. (2014). The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100084"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3945\/jn.115.229476","article-title":"Long-term immunomodulatory effects of a mediterranean diet in adults at high risk of cardiovascular disease in the prevencion con Dieta mediterranea (PREDIMED) randomized controlled trial","volume":"146","author":"Casas","year":"2016","journal-title":"J. Nutr."},{"key":"ref_55","first-page":"1816","article-title":"Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET\/CT","volume":"45","author":"Kupzov","year":"2004","journal-title":"J. Nucl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2967\/jnumed.108.052233","article-title":"Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction","volume":"49","author":"Lee","year":"2008","journal-title":"J. Nucl. Med."},{"key":"ref_57","first-page":"1706","article-title":"Oncological applications of FDG pet imaging","volume":"40","author":"Delbeke","year":"1999","journal-title":"J. Nucl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.2293021168","article-title":"Fluorodeoxyglucose uptake in the aortic wall at PET\/CT: Possible finding for active atherosclerosis","volume":"229","author":"Tatsumi","year":"2003","journal-title":"Radiology"},{"key":"ref_59","first-page":"1278","article-title":"Association of vascular 18F-FDG uptake with vascular calcification","volume":"46","author":"Dunphy","year":"2005","journal-title":"J. Nucl. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.jacc.2006.03.069","article-title":"Simvastatin attenuates plaque inflammation: Evaluation by fluorodeoxyglucose positron emission tomography","volume":"48","author":"Tahara","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/snuc.2002.29279","article-title":"18F FDG uptake in the large arteries: A correlation study with the atherogenic risk factors","volume":"32","author":"Yun","year":"2002","journal-title":"Semin. Nucl. Med."},{"key":"ref_62","first-page":"1301","article-title":"High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue","volume":"36","author":"Yamada","year":"1995","journal-title":"J. Nucl. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","article-title":"Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography","volume":"105","author":"Rudd","year":"2002","journal-title":"Circulation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcmg.2010.01.004","article-title":"Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina","volume":"3","author":"Rogers","year":"2010","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_65","first-page":"1245","article-title":"(18)F-FDG accumulation in atherosclerotic plaques: Immunohistochemical and pet imaging study","volume":"45","author":"Ogawa","year":"2004","journal-title":"J. Nucl. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/eurheartj\/ehm245","article-title":"The prevalence of inflammation in carotid atherosclerosis: Analysis with fluorodeoxyglucose-positron emission tomography","volume":"28","author":"Tahara","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","article-title":"(18)fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: Implications for atherosclerosis therapy trials","volume":"50","author":"Rudd","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2967\/jnumed.107.050294","article-title":"Atherosclerosis inflammation imaging with 18F-FDG pet: Carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations","volume":"49","author":"Rudd","year":"2008","journal-title":"J. Nucl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacc.2006.11.046","article-title":"Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome","volume":"49","author":"Tahara","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2015.10.016","article-title":"Association of pooled cohort risk scores with vascular inflammation and coronary artery calcification in Korean adults","volume":"65","author":"Yoo","year":"2016","journal-title":"Metabolism"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2967\/jnumed.110.080838","article-title":"Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: Analysis with 18F-FDG pet","volume":"52","author":"Yoo","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/ATVBAHA.110.220673","article-title":"Association of adiponectin, resistin, and vascular inflammation: Analysis with 18F-fluorodeoxyglucose positron emission tomography","volume":"31","author":"Choi","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/ATVBAHA.116.307293","article-title":"Vascular inflammation evaluated by [18F]-fluorodeoxyglucose-positron emission tomography\/computed tomography is associated with endothelial dysfunction","volume":"36","author":"Honda","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosissup.2005.02.003","article-title":"Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease","volume":"6","author":"Matsuzawa","year":"2005","journal-title":"Atheroscler. Suppl."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2003.12.104","article-title":"Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: A new insight into adipocytokine-endothelial cell interactions","volume":"314","author":"Kawanami","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lfs.2008.11.004","article-title":"Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages","volume":"84","author":"Lee","year":"2009","journal-title":"Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","article-title":"The role of resistin as a regulator of inflammation: Implications for various human pathologies","volume":"133","author":"Filkova","year":"2009","journal-title":"Clin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Hong, H.C., Hwang, S.Y., Park, S., Ryu, J.Y., Choi, H.Y., Yoo, H.J., Seo, J.A., Kim, S.G., Kim, N.H., and Baik, S.H. (2015). Implications of pericardial, visceral and subcutaneous adipose tissue on vascular inflammation measured using 18FDG-PET\/CT. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135294"},{"key":"ref_82","first-page":"1211","article-title":"Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography\/computed tomography imaging: What leonardo da vinci could not see","volume":"19","author":"Cocker","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jcmg.2011.04.020","article-title":"Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced mr imaging","volume":"4","author":"Vucic","year":"2011","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_84","first-page":"1845","article-title":"Application of 18F-FDG pet for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques","volume":"47","author":"Ogawa","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6B","DOI":"10.1016\/S0002-9149(88)80044-4","article-title":"In vivo inhibition of foam cell development by probucol in watanabe rabbits","volume":"62","author":"Steinberg","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.164.12.6503","article-title":"Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells","volume":"164","author":"Marx","year":"2000","journal-title":"J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/01.RES.0000031271.20771.4F","article-title":"Vascular inflammation is negatively autoregulated by interaction between CCAAT\/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma","volume":"91","author":"Takata","year":"2002","journal-title":"Circ. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.21.3.365","article-title":"Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice","volume":"21","author":"Collins","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice","volume":"106","author":"Li","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1001\/jama.296.21.joc60158","article-title":"Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: A randomized trial","volume":"296","author":"Mazzone","year":"2006","journal-title":"JAMA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.299.13.1561","article-title":"Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: The PERISCOPE randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the proactive study (PROspective pioglitazone clinical trial in macrovascular events): A randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2017.04.004","article-title":"Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [18F]FDG uptake in Ldlr-\/-Apob100\/100mice","volume":"263","author":"Hellberg","year":"2017","journal-title":"Atherosclerosis"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/10\/1382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:23:00Z","timestamp":1760196180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/10\/1382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":93,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["nu10101382"],"URL":"https:\/\/doi.org\/10.3390\/nu10101382","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2018,9,28]]}}}